Supplementary Figure S4 from C-Terminal Truncation and Fusion Partner Determine Oncogenicity of FGFR3

2026 Open access

Read full text Summarise with VIRAT
Authors: Julia Yemelyanenko, Jinhyuk Bhin, Eline van der Burg, Anne Paulien Drenth, Jessica Lee, Catrin Lutz, Lea Dörner, Ellen Wientjens, Sjoerd Klarenbeek, Ji‐Ying Song, Hyeonjin Moon, Stefano Annunziato
+9 more Natalie Proost, Bjørn Siteur, Jeffrey S. Ross, Marieke van de Ven, Olaf van Tellingen, Shridar Ganesan, Lodewyk F.A. Wessels, Daniel Zingg, Jos Jonkers
DOI: 10.1158/0008-5472.31744782
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Top 9 co-occurring driver genes in 123 FGFR3 E18-truncated human lung cancers identified in the FMI cohort, and histological evaluation of mouse lungs expressing Fgfr3 variants

Fields of Study & Subjects

Fibroblast Growth Factor Research Lung Cancer Treatments and Mutations Cancer Genomics and Diagnostics

Publication details

Publication date
16 March 2026
Language
EN